» Articles » PMID: 20035896

Recent Advances in Molecular Imaging Biomarkers in Cancer: Application of Bench to Bedside Technologies

Overview
Specialty Pharmacology
Date 2009 Dec 29
PMID 20035896
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular imaging is the visualization, characterization and measurement of biological processes at the molecular and cellular level. In oncology, molecular imaging approaches can be directly applied as translational biomarkers of disease progression. In this article, selected imaging modalities are discussed with respect to this role. Recent studies focusing on emerging imaging biomarkers and new developments in the field are highlighted. Importantly, because ex vivo or tissue-based imaging now represents an important tool in the discovery and validation of oncology biomarkers, special attention is given to this resurgent field.

Citing Articles

Nanobodies as , non-invasive, imaging agents.

Harmand T, Islam A, Pishesha N, Ploegh H RSC Chem Biol. 2021; 2(3):685-701.

PMID: 34212147 PMC: 8190910. DOI: 10.1039/d1cb00023c.


Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions.

Klingler M, Hormann A, von Guggenberg E Curr Med Chem. 2020; 27(41):7112-7132.

PMID: 32586246 PMC: 7116483. DOI: 10.2174/0929867327666200625143035.


Gastric cancer and imaging biomarkers: Part 1 - a critical review of DW-MRI and CE-MDCT findings.

Giganti F, Tang L, Baba H Eur Radiol. 2018; 29(4):1743-1753.

PMID: 30280246 PMC: 6420485. DOI: 10.1007/s00330-018-5732-4.


SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic.

Wang X, Feng H, Zhao S, Xu J, Wu X, Cui J Oncotarget. 2017; 8(12):20476-20495.

PMID: 28108738 PMC: 5386778. DOI: 10.18632/oncotarget.14730.


Molecular and clinical implementations of ovarian cancer mouse avatar models.

Zayed A, Mandrekar S, Haluska P Chin Clin Oncol. 2015; 4(3):30.

PMID: 26408297 PMC: 4750944. DOI: 10.3978/j.issn.2304-3865.2015.04.01.